GB9407386D0
(en)
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
DE19821625C1
(de)
*
|
1998-05-15 |
2000-01-05 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
US6294199B1
(en)
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
EP1064937A1
(en)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
NZ517833A
(en)
*
|
1999-08-20 |
2004-01-30 |
Ferrosan As |
Oral delivery of antioxidants vitamin C and vitamin E combinations in slow- and plain-release formulations for treating oxidative stress
|
BR0013719A
(pt)
*
|
1999-09-02 |
2002-07-23 |
Nostrum Pharmaceuticals Inc |
Dosagem oral de liberaçâo controlada, apropriada para administração oral
|
CN101804041A
(zh)
*
|
1999-09-28 |
2010-08-18 |
灵药生物技术有限公司 |
含有尼美舒利的控释组合物
|
EP1138330A1
(en)
*
|
1999-12-23 |
2001-10-04 |
Warner-Lambert Company |
Combination of trimebutine with an opioid analgesic
|
BR0007360A
(pt)
*
|
1999-12-23 |
2001-08-14 |
Johnson & Johnson |
Composição de liberação controlada
|
PT1251832E
(pt)
*
|
2000-02-04 |
2007-01-31 |
Depomed Inc |
Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
US20070141107A1
(en)
*
|
2000-03-15 |
2007-06-21 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
US6372252B1
(en)
*
|
2000-04-28 |
2002-04-16 |
Adams Laboratories, Inc. |
Guaifenesin sustained release formulation and tablets
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
AU2001292185A1
(en)
|
2000-10-12 |
2002-04-22 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
WO2002036126A1
(en)
*
|
2000-10-30 |
2002-05-10 |
Lupin Limited |
Rapidly disintegrating sustained release cefuroxime axetil composition
|
KR100778835B1
(ko)
*
|
2000-12-28 |
2007-11-22 |
엘지.필립스 엘시디 주식회사 |
액정표시장치의 제조방법
|
KR100685945B1
(ko)
|
2000-12-29 |
2007-02-23 |
엘지.필립스 엘시디 주식회사 |
액정표시장치 및 그 제조방법
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
US20030032675A1
(en)
*
|
2001-02-15 |
2003-02-13 |
Franz G. Andrew |
Manufacture of thyroid hormone tablets having consistent active moiety amounts
|
US20030224047A1
(en)
*
|
2001-02-15 |
2003-12-04 |
Franz G. Andrew |
Levothyroxine compositions and methods
|
WO2002064093A2
(en)
*
|
2001-02-15 |
2002-08-22 |
King Pharmaceuticals, Inc. |
Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
|
KR100982753B1
(ko)
*
|
2001-04-05 |
2010-09-16 |
콜라제넥스 파마슈티칼스, 인크 |
테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
|
CA2343949A1
(en)
*
|
2001-04-12 |
2002-10-12 |
Bernard Charles Sherman |
Benazepril hydrochloride tablet formulations
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
GB0114069D0
(en)
*
|
2001-06-08 |
2001-08-01 |
Smithkline Beecham Plc |
Composition
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
US20030180353A1
(en)
*
|
2001-08-10 |
2003-09-25 |
Franz G. Andrew |
Stabilized pharmaceutical compositions
|
US20030190349A1
(en)
*
|
2001-08-10 |
2003-10-09 |
Franz G. Andrew |
Methods of stabilizing pharmaceutical compositions
|
US20030198667A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz Andrew G. |
Methods of producing dispersible pharmaceutical compositions
|
US20030203967A1
(en)
*
|
2001-08-14 |
2003-10-30 |
Franz G. Andrew |
Levothyroxine compositions having unique Tmax properties
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030198672A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique triidothyronine plasma AUC properties
|
US20030195253A1
(en)
*
|
2001-08-14 |
2003-10-16 |
Franz G. Andrew |
Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
|
US20030199586A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Unique levothyroxine aqueous materials
|
US20040043066A1
(en)
*
|
2001-10-29 |
2004-03-04 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
US20030099699A1
(en)
*
|
2001-11-13 |
2003-05-29 |
Hanshew Dwight D. |
Storage stable thyroxine active drug formulations and methods for their production
|
US6645526B2
(en)
*
|
2001-11-13 |
2003-11-11 |
Mylan Pharmaceuticals, Inc. |
Storage stable thyroxine active drug formulations and methods for their production
|
US6863901B2
(en)
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US7229644B2
(en)
*
|
2002-05-23 |
2007-06-12 |
Cephalon, Inc. |
Pharmaceutical formulations of modafinil
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
PA8578501A1
(es)
|
2002-07-25 |
2005-02-04 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
AR040588A1
(es)
*
|
2002-07-26 |
2005-04-13 |
Schering Corp |
Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
|
US20040116532A1
(en)
*
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
KR20100137023A
(ko)
*
|
2002-09-20 |
2010-12-29 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
MXPA02010828A
(es)
*
|
2002-11-04 |
2004-07-16 |
Leopoldo Espinosa Abdala |
Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
US20040253311A1
(en)
*
|
2002-12-18 |
2004-12-16 |
Roger Berlin |
Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
|
SI1575566T1
(sl)
*
|
2002-12-26 |
2012-08-31 |
Pozen Inc |
Veäśplastna dozirna oblika vsebujoäśa naproksen in triptane
|
TWI355276B
(en)
*
|
2003-01-14 |
2012-01-01 |
Akira Tsuji |
Gastrointestinal absorption enhancer mediated by p
|
CA2554012A1
(en)
*
|
2003-01-21 |
2004-08-05 |
Smartrix Technologies Inc. |
Oral dosage formulation
|
ATE401866T1
(de)
*
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
FR2851734B1
(fr)
*
|
2003-02-28 |
2006-06-09 |
Galenix Innovations |
Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
|
JP2006520390A
(ja)
*
|
2003-03-14 |
2006-09-07 |
ムルイェ、ニルマル |
徐放性錠剤の製造方法
|
US20040192781A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Haley Eugene T. |
Method of administration for metoclopramide and pharmaceutical formulation therefor
|
PL1615622T3
(pl)
|
2003-04-07 |
2012-12-31 |
Supernus Pharmaceuticals Inc |
Preparaty doksycyklin do jednorazowego dziennego podawania
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
US6863830B1
(en)
*
|
2003-08-21 |
2005-03-08 |
Biolab Services, Inc. |
Dual layer tablet, method of making and use thereof
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050118267A1
(en)
*
|
2003-09-19 |
2005-06-02 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
MXPA06003450A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US20050084531A1
(en)
*
|
2003-10-16 |
2005-04-21 |
Jatin Desai |
Tablet with aqueous-based sustained release coating
|
EP1715852A2
(en)
*
|
2004-01-06 |
2006-11-02 |
Panacea Biotec Ltd. |
Non-disintegrating oral solid composition of high dose of water soluble drugs
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
WO2005099672A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
ATE399539T1
(de)
*
|
2004-04-30 |
2008-07-15 |
Topotarget Germany Ag |
Histondeacetylase-inhibitor enthaltende formulierung zur zweiphasigen freisetzung
|
FR2873113B1
(fr)
*
|
2004-07-19 |
2007-06-15 |
Eurotab Sa |
Produit solide compacte bicouche de purification d'eau
|
US20060020007A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Roger Berlin |
Compositions containing policosanol and biotin and their pharmaceutical uses
|
PL1789021T3
(pl)
*
|
2004-08-13 |
2012-04-30 |
Boehringer Ingelheim Int |
Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
|
KR20080046751A
(ko)
|
2004-09-01 |
2008-05-27 |
유로-셀띠끄 소시에떼 아노님 |
용량 비례적 정상 상태 Cave및 AUC를 갖고, 용량비례적 단일 용량 Cmax보다 작은 오피오이드성 제형
|
US20070129402A1
(en)
*
|
2004-12-27 |
2007-06-07 |
Eisai Research Institute |
Sustained release formulations
|
EP1830886B1
(en)
*
|
2004-12-27 |
2016-04-13 |
Eisai R&D Management Co., Ltd. |
Method for stabilizing anti-dementia drug
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
US20060280789A1
(en)
*
|
2004-12-27 |
2006-12-14 |
Eisai Research Institute |
Sustained release formulations
|
WO2006081347A2
(en)
*
|
2005-01-26 |
2006-08-03 |
Elan Pharma International Limited |
Controlled release compositions comprising an antipsychotic agent
|
DE102005019458A1
(de)
*
|
2005-04-25 |
2006-10-26 |
Grünenthal GmbH |
Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
|
JP5597343B2
(ja)
*
|
2005-04-28 |
2014-10-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬を含有する組成物
|
EP1888045B1
(en)
*
|
2005-05-24 |
2010-09-08 |
Flamel Technologies |
Oral pharmaceutical composition for treating a cox-2 mediated condition
|
US20070020333A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Chin-Chih Chiang |
Controlled release of hypnotic agents
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
US8795723B2
(en)
*
|
2005-09-09 |
2014-08-05 |
Angelini Pharma Inc. |
Sustained drug release compositions
|
AU2005336956A1
(en)
*
|
2005-09-28 |
2007-04-12 |
Teva Pharmaceutical Industries Ltd. |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
DE102005048293A1
(de)
*
|
2005-10-08 |
2007-04-12 |
Sanofi-Aventis Deutschland Gmbh |
Retardformulierung für Pralnacasan
|
DE602006008339D1
(en)
*
|
2005-11-18 |
2009-09-17 |
Synhton B V |
Zolpidemtabletten
|
EP1970055B1
(en)
|
2005-12-29 |
2010-11-24 |
Osmotica Kereskedelmi És Szolgáltató Kft |
Multi-layered tablet with triple release combination
|
CZ300698B6
(cs)
*
|
2006-06-16 |
2009-07-22 |
Zentiva, A. S. |
Tableta s obsahem metforminu
|
FR2906801B1
(fr)
*
|
2006-10-05 |
2008-12-12 |
Eurotab Sa |
Produit solide compacte bicouche de potabilisaton d'eau et procede de preparation.
|
CA2664893C
(en)
*
|
2006-10-30 |
2015-01-27 |
Hanall Pharmaceutical Company, Ltd. |
Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
|
US8394845B2
(en)
|
2006-10-30 |
2013-03-12 |
Hanall Biopharma Co., Ltd. |
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
|
US20080207593A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Collegium Pharmaceutical, Inc. |
Antihistamine Combination
|
EP2123275A1
(en)
*
|
2007-03-15 |
2009-11-25 |
Toyo Boseki Kabushiki Kaisha |
Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
|
WO2008142627A2
(en)
*
|
2007-05-17 |
2008-11-27 |
Ranbaxy Laboratories Limited |
Multilayered modified release formulation comprising amoxicillin and clavulanate
|
AU2008261957A1
(en)
|
2007-06-08 |
2008-12-18 |
Addrenex Pharmaceuticals, Inc. |
Extended release formulation and method of treating adrenergic dysregulation
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
US8404275B2
(en)
*
|
2007-07-01 |
2013-03-26 |
Vitalis Llc |
Combination tablet with chewable outer layer
|
WO2009024858A1
(en)
*
|
2007-08-22 |
2009-02-26 |
Aurobindo Pharma Limited |
Controlled release dosage form of galantamine
|
MX336494B
(es)
*
|
2007-10-16 |
2016-01-21 |
Paladin Labs Inc |
Composicion de bicapas para la liberacion controlada de acetaminofeno y tramadol.
|
CA2707980C
(en)
|
2007-12-17 |
2015-05-12 |
Labopharm Inc. |
Misuse preventative, controlled release formulation
|
FR2927965B1
(fr)
*
|
2008-02-22 |
2010-06-04 |
Valeo Materiaux De Friction Sa |
Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
|
WO2009154810A2
(en)
*
|
2008-02-25 |
2009-12-23 |
Dr. Reddy's Laboratories Ltd. |
Delivery systems for multiple active agents
|
WO2009118764A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Pharmaceutical composition comprising diclofenac and paracetamol
|
JP2009256237A
(ja)
*
|
2008-04-16 |
2009-11-05 |
Daiichi Sankyo Healthcare Co Ltd |
固形製剤
|
KR101687781B1
(ko)
|
2008-08-15 |
2016-12-20 |
데포메드 인코퍼레이티드 |
Cns 장애의 치료 및 예방을 위한 위 체류성 약학적 조성물
|
AU2009290712A1
(en)
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
WO2010045656A2
(en)
*
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
US20110217371A1
(en)
*
|
2008-11-10 |
2011-09-08 |
Amorepacific Corporation |
Controlled-release microparticles and method of preparing same
|
EP2367541B1
(en)
|
2008-12-16 |
2014-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
PE20120421A1
(es)
*
|
2009-01-23 |
2012-05-04 |
Hoffmann La Roche |
Composicion farmaceutica que comprende aleglitazar
|
KR101050076B1
(ko)
*
|
2009-02-04 |
2011-07-19 |
한국유나이티드제약 주식회사 |
제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
|
US20120064159A1
(en)
*
|
2009-05-28 |
2012-03-15 |
Aptapharma, Inc. |
Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
|
JP2012531409A
(ja)
|
2009-06-25 |
2012-12-10 |
アストラゼネカ・アクチエボラーグ |
Nsaid関連潰瘍を発症するリスクがある患者の処置方法
|
WO2010151697A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
CN102883601A
(zh)
|
2009-12-02 |
2013-01-16 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
WO2011080716A2
(en)
|
2010-01-04 |
2011-07-07 |
Wockhardt Limited |
Pharmaceutical composition for modified delivery of actives
|
PL2394644T3
(pl)
*
|
2010-05-04 |
2014-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Preparat trimetazydyny o różnych profilach uwalniania
|
BR112012032816A2
(pt)
*
|
2010-06-22 |
2016-11-08 |
Twi Pharmaceuticals |
composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz
|
CN102727496A
(zh)
*
|
2011-04-12 |
2012-10-17 |
上海双健现代药物技术咨询有限公司 |
一种复方抗结核药口服固体制剂及其制备方法
|
CN107296798A
(zh)
|
2011-10-28 |
2017-10-27 |
维塔利斯公司 |
抗发红组合物
|
BR112014016085A8
(pt)
|
2011-12-28 |
2017-07-04 |
Pozen Inc |
composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
|
PL2809305T3
(pl)
*
|
2012-01-31 |
2016-03-31 |
Sanovel Ilac Sanayi Ve Ticaret As |
Formulacje tabletek dwuwarstwowych flurbiprofenu i glukozaminy
|
EP2817001A1
(en)
*
|
2012-02-20 |
2014-12-31 |
Lupin Limited |
Bilayer tablet of dronedarone
|
MX355912B
(es)
|
2012-02-22 |
2018-05-04 |
Duchesnay Inc |
Formulación de doxilamina y piridoxina y/o sus metabolitos o sales.
|
US20140072671A1
(en)
*
|
2012-06-29 |
2014-03-13 |
Adam Auerbach |
Multi-component oral delivery systems and uses thereof
|
US10835495B2
(en)
|
2012-11-14 |
2020-11-17 |
W. R. Grace & Co.-Conn. |
Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
|
WO2014075155A1
(pt)
*
|
2012-11-14 |
2014-05-22 |
Diffucap Chemobras Química E Farmacêutica Ltda |
Combinação farmacêutica contendo agente analgésico e agente antiespasmódico
|
RU2521572C1
(ru)
*
|
2012-12-21 |
2014-06-27 |
Федеральное государственное бюджетное учреждение науки Институт химии растворов им. Г.А. Крестова Российской академии наук (ИХР РАН) |
Сокристаллическая форма фенбуфена
|
KR20150126383A
(ko)
*
|
2013-03-12 |
2015-11-11 |
바이오히트 오와이제이 |
위장관 내의 알데하이드에 결합하는 경구 투여용 조성물
|
ES2674045T3
(es)
|
2013-04-29 |
2018-06-27 |
Clariant Healthcare Packaging (France) S.A.S. |
Tapa para un recipiente
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
US9452181B2
(en)
|
2013-07-22 |
2016-09-27 |
Duchesnay Inc. |
Composition for the management of nausea and vomiting
|
JP6379194B2
(ja)
|
2013-07-22 |
2018-08-22 |
デュシネイ・インコーポレイテッド |
悪心及び嘔吐の管理のための組成物
|
WO2015027303A1
(pt)
*
|
2013-08-28 |
2015-03-05 |
Diffucap Chemobras Quimica E Farmaceutica Ltda |
Procedimento. de fabricação de combinação farmacêutica contendo agente analgésico e agente antiespasmódico e combinação farmacêutica
|
WO2015063669A1
(en)
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
|
US9526703B2
(en)
|
2014-08-29 |
2016-12-27 |
Duchesnay Inc. |
Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
WO2016029290A1
(en)
*
|
2014-08-29 |
2016-03-03 |
Duchesnay Inc. |
Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
CA2936740C
(en)
*
|
2014-10-31 |
2017-10-10 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US10413403B2
(en)
*
|
2015-07-14 |
2019-09-17 |
Boston Scientific Scimed, Inc. |
Prosthetic heart valve including self-reinforced composite leaflets
|
EP3324971B1
(en)
*
|
2015-07-23 |
2024-06-12 |
Athena Pharmaceutiques SAS |
Zolpidem composition and process for preparing the same
|
IL272834B1
(en)
|
2017-08-24 |
2024-04-01 |
Adamas Pharma Llc |
Compositions of amantadine, their preparation, and methods of use
|
EP3675831A1
(en)
|
2017-08-29 |
2020-07-08 |
Conrig Pharma ApS |
Composition comprising suplatast tosilate
|
EP4079297A4
(en)
*
|
2019-12-19 |
2023-03-08 |
Celltrion, Inc. |
PHARMACEUTICAL FORMULATION COMPRISING CIBENZOLINE OR A SALT THEREOF
|
CN114432300B
(zh)
*
|
2022-02-16 |
2023-08-01 |
平顶山市第二人民医院 |
含有比索洛尔和依那普利的药物组合物及其工艺
|